These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 15207130)

  • 1. [Visceral leishmaniasis related to infliximab administration].
    Romaní-Costa V; Sánchez C; Moyá F; Estany C
    Enferm Infecc Microbiol Clin; 2004 May; 22(5):310. PubMed ID: 15207130
    [No Abstract]   [Full Text] [Related]  

  • 2. Visceral leishmaniasis in a patient with psoriatic arthritis treated with infliximab: reactivation of a latent infection?
    Tektonidou MG; Skopouli FN
    Clin Rheumatol; 2008 Apr; 27(4):541-2. PubMed ID: 17963018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visceral leishmaniasis as an unusual infectious complication in a patient with Crohn's disease treated with infliximab.
    Hernández M; González-Lama Y; Ramos A; Martínez-Ruiz R; Calvo M; Matallana V; Vera MI; Suarez C; Blázquez I; Abreu L
    Gastroenterol Hepatol; 2015; 38(6):411-2. PubMed ID: 25443540
    [No Abstract]   [Full Text] [Related]  

  • 4. [Visceral leishmaniasis infection in a rheumatoid arthritis patient treated with adalimumab: a case description and literature review].
    Moreno D; Martínez P; Berbegal J; Femenia M
    Enferm Infecc Microbiol Clin; 2010 Apr; 28(4):261-2. PubMed ID: 19729230
    [No Abstract]   [Full Text] [Related]  

  • 5. Visceral leishmaniasis infection in a rheumatoid arthritis patient treated with infliximab.
    Fabre S; Gibert C; Lechiche C; Dereure J; Jorgensen C; Sany J
    Clin Exp Rheumatol; 2005; 23(6):891-2. PubMed ID: 16396712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrophage activation syndrome revealing disseminated tuberculosis in a patient on infliximab.
    André V; Liddell C; Guimard T; Tanguy G; Cormier G
    Joint Bone Spine; 2013 Jan; 80(1):109-10. PubMed ID: 23286892
    [No Abstract]   [Full Text] [Related]  

  • 7. Cutaneous and visceral leishmaniasis during anti-TNFα therapy.
    Guarneri C; Bevelacqua V; Patterson JW; Tchernev G
    Wien Med Wochenschr; 2017 Mar; 167(3-4):78-82. PubMed ID: 27832423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse reactions during biological drug therapy in psoriasis:clinical series and a review of the literature.
    Montesu MA; Addis GM; Satta R; Cottoni F
    G Ital Dermatol Venereol; 2011 Aug; 146(4):273-81. PubMed ID: 21785393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B-cell lymphoma in a psoriatic patient treated with infliximab.
    Bardazzi F; Antonucci VA; Alessandrini AM; Baraldi C; Tengattini V; Patrizi A
    Eur J Dermatol; 2013 Apr; 23(2):264-5. PubMed ID: 23568543
    [No Abstract]   [Full Text] [Related]  

  • 10. [Rare opportunistic disease in a patient treated with immunosuppressive therapy for rheumatoid arthritis].
    Baixauli Rubio A; Rodríguez Górriz E; Campos Fernández C; Calvo Catalá J; García Vicente S
    An Med Interna; 2003 May; 20(5):276-7. PubMed ID: 12831311
    [No Abstract]   [Full Text] [Related]  

  • 11. Collodion-like membrane in a newborn exposed to infliximab.
    Offiah M; Brodell RT; Campbell LR; Wyatt JP
    J Am Acad Dermatol; 2014 Jul; 71(1):e22-3. PubMed ID: 24947707
    [No Abstract]   [Full Text] [Related]  

  • 12. An atypical presentation of visceral leishmaniasis infection in a patient with rheumatoid arthritis treated with infliximab.
    Kritikos K; Haritatos E; Tsigkos S; Gounari P; Skrapari I; Gounaris T; Sioula E
    J Clin Rheumatol; 2010 Jan; 16(1):38-9. PubMed ID: 20051756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for opportunistic infections in infliximab-treated patients: the importance of screening in prevention.
    Garcia-Vidal C; Rodríguez-Fernández S; Teijón S; Esteve M; Rodríguez-Carballeira M; Lacasa JM; Salvador G; Garau J
    Eur J Clin Microbiol Infect Dis; 2009 Apr; 28(4):331-7. PubMed ID: 18797940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visceral leishmaniasis in a psoriatic arthritis patient treated with methotrexate.
    Hadjipetrou A; Anyfantakis D; Gkogkou A; Palla K; Lagoudaki E; Milonaki T; Kastanakis S
    Infez Med; 2014 Sep; 22(3):230-5. PubMed ID: 25269966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spinal epidural abscess associated with infliximab treatment for psoriatic arthritis. Case report.
    Smith AP; Musacchio MJ; O'Toole JE
    J Neurosurg Spine; 2008 Sep; 9(3):261-4. PubMed ID: 18928222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visceral leishmaniasis reactivation in transplant patients: a minireview with report of a new case.
    Postorino MC; Bellantoni M; Catalano C; Caridi G; De Rosa M; Seck S; Enia G
    J Nephrol; 2011; 24(4):530-4. PubMed ID: 21607915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visceral leishmaniasis and anti-TNF-alpha therapy: case report and review of the literature.
    De Leonardis F; Govoni M; Lo Monaco A; Trotta F
    Clin Exp Rheumatol; 2009; 27(3):503-6. PubMed ID: 19604446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multidrug resistant miliary tuberculosis during infliximab therapy despite tuberculosis screening.
    Gin A; Dolianitis C
    Australas J Dermatol; 2014 May; 55(2):140-1. PubMed ID: 23713793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Listeria endocarditis in a patient with psoriatic arthritis on infliximab: are biologic agents as treatment for inflammatory arthritis increasing the incidence of Listeria infections?
    Kelesidis T; Salhotra A; Fleisher J; Uslan DZ
    J Infect; 2010 May; 60(5):386-96. PubMed ID: 20176052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Interpretation of laboratory data during cryptic leishmaniasis in dog].
    Gravino AE
    Parassitologia; 2004 Jun; 46(1-2):227-9. PubMed ID: 15305723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.